Cardlytics, Inc.
DE ˙ DB ˙ US14161W1053
0,45 € ↓ -0,04 (-8,23%)
2026-06-05
DEL PRIS
SecurityDE:CYX / Cardlytics, Inc.
InstitutionLPL Financial LLC
Latest Disclosed Ownership437,412 shares
Latest Disclosed Value $ 459,283
LPL Financial LLC reports 1.79% decrease in ownership of CYX / Cardlytics, Inc.

On May 6, 2026 - LPL Financial LLC filed a 13F-HR form disclosing ownership of 437,412 shares of Cardlytics, Inc. (DE:CYX) valued at $323,947 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 445,387 shares of Cardlytics, Inc.. This represents a change in shares of -1.79% during the quarter. The current value of the position is $195,086 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F CARDLYTICS COM 14161W105 437,412 -7,975 -1.79 459 -10.35 0.0001
2026-02-11 2025-12-31 13F CARDLYTICS COM 14161W105 445,387 -24,737 -5.26 512 -55.17 0.0001
2025-11-12 2025-09-30 13F CARDLYTICS COM 14161W105 470,124 -578,534 -55.17 1,142 -33.80 0.0003
2025-08-12 2025-06-30 13F CARDLYTICS COM 14161W105 1,048,658 189,252 22.02 1,725 10.29 0.0006
2025-05-07 2025-03-31 13F CARDLYTICS COM 14161W105 859,406 200,087 30.35 1,564 -36.06 0.0006
2025-02-11 2024-12-31 13F CARDLYTICS COM 14161W105 659,319 -25,467 -3.72 2,446 11.64 0.0010
2024-11-08 2024-09-30 13F CARDLYTICS COM 14161W105 684,786 93,614 15.84 2,191 -54.85 0.0010
2024-08-07 2024-06-30 13F CARDLYTICS COM 14161W105 591,172 72,322 13.94 4,854 -35.45 0.0024
2024-05-10 2024-03-31 13F CARDLYTICS COM 14161W105 518,850 65,446 14.43 7,518 80.07 0.0040
2024-02-14 2023-12-31 13F CARDLYTICS COM 14161W105 453,404 29,254 6.90 4,176 -40.34 0.0025
2023-11-13 2023-09-30 13F CARDLYTICS COM 14161W105 424,150 91,400 27.47 6,998 232.92 0.0049
2023-07-31 2023-06-30 13F CARDLYTICS COM 14161W105 332,750 81,409 32.39 2,103 146.42 0.0015
2023-05-10 2023-03-31 13F CARDLYTICS COM 14161W105 251,341 25,327 11.21 853 -34.69 0.0007
2023-02-07 2022-12-31 13F CARDLYTICS COM 14161W105 226,014 -49,162 -17.87 1,306 -49.52 0.0011
2022-11-14 2022-09-30 13F CARDLYTICS COM 14161W105 275,176 82,118 42.54 2,587 -39.93 0.0025
2022-08-12 2022-06-30 13F CARDLYTICS COM 14161W105 193,058 55,952 40.81 4,307 -42.86 0.0041
2022-05-16 2022-03-31 13F CARDLYTICS COM 14161W105 137,106 8,613 6.70 7,538 -11.23 0.0065
2022-02-14 2021-12-31 13F CARDLYTICS COM 14161W105 128,493 5,220 4.23 8,492 -17.94 0.0071
2021-11-15 2021-09-30 13F CARDLYTICS COM 14161W105 123,273 26,641 27.57 10,348 -15.63 0.0097
2021-08-13 2021-06-30 13F CARDLYTICS COM 14161W105 96,632 26,286 37.37 12,265 58.93 0.0124
2021-05-14 2021-03-31 13F CARDLYTICS COM 14161W105 70,346 2,301 3.38 7,717 -20.57 0.0089
2021-02-12 2020-12-31 13F CARDLYTICS COM 14161W105 68,045 68,045 9,715 0.0126
2020-11-09 2020-09-30 13F CARDLYTICS COM 14161W105 0 -6,937 -100.00 0 -100.00
2020-08-13 2020-06-30 13F CARDLYTICS COM 14161W105 6,937 6,937 485 0.0008
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.